129 related articles for article (PubMed ID: 17591314)
1. Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
Girona E; Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Solís J; García-Sepulcre MF; Oliver-García I
South Med J; 2007 Jun; 100(6):601-4. PubMed ID: 17591314
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIIa for severe gastrointestinal hemorrhage associated with Crohn disease.
Filik L
South Med J; 2007 Jun; 100(6):559. PubMed ID: 17591308
[No Abstract] [Full Text] [Related]
3. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Zülfikar B; Kayiran SM
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):261-3. PubMed ID: 15060424
[TBL] [Abstract][Full Text] [Related]
5. [Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure].
Liu M; Wang G; Ma Q; Ren J; Guo L; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1215-6. PubMed ID: 25176101
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia.
Kurekci AE; Atay AA; Okutan V; Yavuz ST; Ozcan O
Blood Coagul Fibrinolysis; 2005 Mar; 16(2):145-7. PubMed ID: 15741803
[TBL] [Abstract][Full Text] [Related]
7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
8. Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer).
Udvardy M; Telek B; Mezey G; Batar P; Altorjay I
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):265-7. PubMed ID: 15060425
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
Tonkic A; Jukic I; Titlic M; Mise S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):385-7. PubMed ID: 15970725
[No Abstract] [Full Text] [Related]
10. Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation.
Ruha AM; Curry SC
Wilderness Environ Med; 2009; 20(2):156-60. PubMed ID: 19594209
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
Bosch J; Thabut D; Albillos A; Carbonell N; Spicak J; Massard J; D'Amico G; Lebrec D; de Franchis R; Fabricius S; Cai Y; Bendtsen F;
Hepatology; 2008 May; 47(5):1604-14. PubMed ID: 18393319
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII in an unselected series of cases with upper gastrointestinal bleeding.
Vilstrup H; Markiewicz M; Biesma D; Brozovic VV; Laminoga N; Malik M; Milanov S; Patch D; Platikanov V
Thromb Res; 2006; 118(5):595-601. PubMed ID: 16325890
[TBL] [Abstract][Full Text] [Related]
13. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
15. Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Karimi M
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S74. PubMed ID: 18544432
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
17. Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa.
Agarwal N; Spahr JE; Rodgers GM
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):205-7. PubMed ID: 17287641
[TBL] [Abstract][Full Text] [Related]
18. Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion.
Yadav SP; Sachdeva A; Bhat S; Katewa S
Pediatr Hematol Oncol; 2010 Feb; 27(1):24-30. PubMed ID: 20121552
[TBL] [Abstract][Full Text] [Related]
19. "Off-license" use of recombinant activated factor VII.
Ghorashian S; Hunt BJ
Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
